SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:umu-104546"
 

Search: onr:"swepub:oai:DiVA.org:umu-104546" > EFNS guidelines for...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Burgunder, J-M (author)

EFNS guidelines for the molecular diagnosis of neurogenetic disorders : motoneuron, peripheral nerve and muscle disorders

  • Article/chapterEnglish2011

Publisher, publication year, extent ...

  • 2011-01-17
  • Wiley-Blackwell,2011
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:umu-104546
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-104546URI
  • https://doi.org/10.1111/j.1468-1331.2010.03069.xDOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Objectives: These EFNS guidelines on the molecular diagnosis of motoneuron disorders, neuropathies and myopathies are designed to summarize the possibilities and limitations of molecular genetic techniques and to provide diagnostic criteria for deciding when a molecular diagnostic work-up is indicated. Search strategy: To collect data about planning, conditions and performance of molecular diagnosis of these disorders, a literature search in various electronic databases was carried out and original papers, meta-analyses, review papers and guideline recommendations reviewed. Results: The best level of evidence for genetic testing recommendation (B) can be found for the disorders with specific presentations, including familial amyotrophic lateral sclerosis, spinal and bulbar muscular atrophy, Charcot-Marie-Tooth 1A, myotonic dystrophy and Duchenne muscular dystrophy. For a number of less common disorders, a precise description of the phenotype, including the use of immunologic methods in the case of myopathies, is considered as good clinical practice to guide molecular genetic testing. Conclusion: These guidelines are provisional and the future availability of molecular-genetic epidemiological data about the neurogenetic disorders under discussion in this article will allow improved recommendation with an increased level of evidence.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Schöls, L (author)
  • Baets, J (author)
  • Andersen, PeterUmeå universitet,Klinisk neurovetenskap(Swepub:umu)pean0001 (author)
  • Gasser, T (author)
  • Szolnoki, Z (author)
  • Fontaine, B (author)
  • Van Broeckhoven, C (author)
  • Di Donato, S (author)
  • De Jonghe, P (author)
  • Lynch, T (author)
  • Mariotti, C (author)
  • Spinazzola, A (author)
  • Tabrizi, S J (author)
  • Tallaksen, C (author)
  • Zeviani, M (author)
  • Harbo, H F (author)
  • Finsterer, J (author)
  • Umeå universitetKlinisk neurovetenskap (creator_code:org_t)

Related titles

  • In:European Journal of Neurology: Wiley-Blackwell18:2, s. 207-E201351-51011468-1331

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view